Advisory Alpha’s Boston Scientific BSX Stock Holding History

Advisory Alpha’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$541K	Sell	8,614 -404	-4%	-$32.3K	0.01%	311
2025 Q4	$860K	Buy	9,018 +584	+7%	+$57.3K	0.02%	213
2025 Q3	$812K	Buy	8,434 +1,575	+23%	+$163K	0.02%	215
2025 Q2	$737K	Buy	6,859 +860	+14%	+$87K	0.02%	209
2025 Q1	$605K	Buy	5,999 +552	+10%	+$55.6K	0.02%	220
2024 Q4	$487K	Sell	5,447 -62	-1%	-$5.46K	0.02%	237
2024 Q3	$462K	Buy	5,509 +10	+0.2%	+$788	0.02%	250
2024 Q2	$423K	Buy	5,499 +113	+2%	+$8.27K	0.02%	236
2024 Q1	$369K	Buy	+5,386	New	+$346K	0.02%	258
2019 Q4	–	Sell	-60	Closed	-$2.32K	–	773
2019 Q3	$2.32K	Buy	+60	New	+$2.54K	﹤0.01%	632
2019 Q2	–	Sell	-21	Closed	-$778	–	179
2019 Q1	$778	Buy	+21	New	+$802	﹤0.01%	615

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Advisory Alpha's BSX Position: Q1 2026 in Review

Advisory Alpha reduced its Boston Scientific (BSX) stake by 4.5% in Q1 2026, selling an estimated $32.3K and leaving 8,614 shares worth $541K. The position accounts for 0.01% of the portfolio, ranked #311.

Advisory Alpha first reported a position in BSX in Q1 2019 and has held it in 11 quarters since. The position peaked at $860K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Advisory Alpha held 8,614 shares of Boston Scientific worth $541K as of Q1 2026.
Advisory Alpha sold 404 Boston Scientific shares in Q1 2026, an estimated $32.3K.
Boston Scientific made up 0.01% of Advisory Alpha's portfolio in Q1 2026, its #311 holding.
Advisory Alpha first reported a position in Boston Scientific in Q1 2019 and has held it in 11 quarters since.
Advisory Alpha's Boston Scientific position peaked at $860K in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Advisory Alpha's 13F filing for Q1 2026, filed 14 May 2026.